MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen

Proteomics - Clinical Applications

Volumn 4, Issue 5, 2010, Pages 511-518

  Hermansson, Monika ^a   Artemenko, Konstantin ^b   Ossipova, Elena ^a   Eriksson, Hanna ^a   Lengqvist, Johan ^a   Makrygiannakis, Dimitrios ^a   Catrina, Anca I ^a   Nicholas, Anthony P ^c   Klareskog, Lars ^a   Savitski, Mikhail ^b   Zubarev, Roman A ^b   Jakobsson, Per Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Citrullination; Fibrinogen; MS; Rheumatoid arthritis

Indexed keywords

FIBRINOGEN;

ADULT; AGED; ARTICLE; CASE REPORT; DEAMINATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

AGED; AMINO ACID SEQUENCE; ARTHRITIS, RHEUMATOID; CITRULLINE; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; PROTEIN PROCESSING, POST-TRANSLATIONAL; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SYNOVIAL MEMBRANE;

EID: 77953799494     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900088     Document Type: Article

References (30)

1. Choy, E. H., Panayi, G. S., Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 2001, 344, 907-916.
2. Silman, A. J., Epidemiology of rheumatoid arthritis. APMIS 1994, 102, 721-728.
3. Shmerling, R. H., Delbanco, T. L., The rheumatoid factor: an analysis of clinical utility. Am. J. Med. 1991, 91, 528-534.
4. Girbal-Neuhauser, E., Durieux, J. J., Arnaud, M., Dalbon, P. et al., The epitopes targeted by the rheumatoid arthritisassociated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J. Immunol. 1999, 162,585-594.
5. Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B., van Venrooij, W. J., Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritisspecific autoantibodies. J. Clin. Invest. 1998, 101, 273-281.
6. Schellekens, G. A., Visser, H., de Jong, B. A., van den Hoogen, F. H. et al., The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000, 43, 155-163.
7. Klareskog, L., Widhe, M., Hermansson, M., Ronnelid, J., Antibodies to citrullinated proteins in arthritis: pathology and promise. Curr. Opin. Rheumatol. 2008, 20, 300-305.
8. Masson-Bessiere, C., Sebbag, M., Durieux, J. J., Nogueira, L. et al., In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin. Exp. Immunol. 2000, 119, 544-552.
9. Klareskog, L., Ronnelid, J., Lundberg, K., Padyukov, L., Alfredsson, L., Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 2008, 26, 651-675.
10. Vossenaar, E. R., Zendman, A. J., van Venrooij, W. J., Pruijn, G. J., PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003, 25, 1106-1118.
11. Gyorgy, B., Toth, E., Tarcsa, E., Falus, A., Buzas, E. I., Citrullination: a posttranslational modification in health and disease. Int. J. Biochem. Cell Biol. 2006, 38, 1662-1677.
12. Bang, H., Egerer, K., Gauliard, A., Luthke, K. et al., Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum. 2007, 56, 2503-2511.
13. Kinloch, A., Tatzer, V., Wait, R., Peston, D. et al., Identification of citrullinated alphaenolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res. Ther. 2005, 7, R1421-R1429.
14. Masson-Bessiere, C., Sebbag, M., Girbal-Neuhauser, E., Nogueira, L. et al., The major synovial targets of the rheu-matoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J. Immunol. 2001, 166, 4177-4184.
15. Vossenaar, E. R., Despres, N., Lapointe, E., van der Heijden, A. et al., Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res. Ther. 2004, 6, R142-R150.
16. Makrygiannakis, D., af Klint, E., Lundberg, I. E., Lofberg, R. et al., Citrullination is an inflammation-dependent process. Ann. Rheum. Dis. 2006, 65, 1219-1222.
17. Wood, D. D., Bilbao, J. M., O'Connors, P., Moscarello, M. A., Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann. Neurol. 1996, 40, 18-24.
18. Hill, J. A., Al-Bishri, J., Gladman, D. D., Cairns, E., Bell, D. A., Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis. J. Rheumatol. 2006, 33, 2115-2119.
19. Nielen, M. M., van der Horst, A. R., van Schaardenburg, D., van der Horst-Bruinsma, I. E. et al., Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Ann. Rheum. Dis. 2005, 64, 1199-1204.
20. Smith, R. D., Anderson, G. A., Lipton, M. S., Pasa-Tolic, L. et al., An accurate mass tag strategy for quantitative and high-throughput proteome measurements. Proteomics 2002, 2, 513-523.
21. Chapuy-Regaud, S., Sebbag, M., Baeten, D., Clavel, C. et al., Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovi-tides. J. Immunol. 2005, 174, 5057-5064.
22. Nicholas, A. P., Whitaker, J. N., Preparation of a monoclonal antibody to citrullinated epitopes: its characterization and some applications to immunohistochemistry in human brain. Glia 2002, 37, 328-336.
23. Wilm, M., Shevchenko, A., Houthaeve, T., Breit, S. et al., Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 1996, 379, 466-469.
24. Asaga, H., Yamada, M., Senshu, T., Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochem. Biophys. Res. Commun. 1998, 243, 641-646.
25. Foulquier, C., Sebbag, M., Clavel, C., Chapuy-Regaud, S. et al., Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflamma-tion. Arthritis Rheum. 2007, 56, 3541-3553.
26. Snir, O., Widhe, M., von Spee, C., Lindberg, J. et al., Multiple antibody reactivities to citrullinated antigens in sera from rheumatoid arthritis patients - association with HLA-DRB1 alleles. Ann. Rheum. Dis. 2009, 68, 736-743.
27. Kubota, K., Yoneyama-Takazawa, T., Ichikawa, K., Determi- nation of sites citrullinated by peptidylarginine deiminase using 18O stable isotope labeling and mass spectrometry. Rapid. Commun. Mass Spectrom. 2005, 19, 683-688.
28. Nakayama-Hamada, M., Suzuki, A., Kubota, K., Takazawa, T. et al., Comparison of enzymatic properties between hPADI2 and hPADI4. Biochem. Biophys. Res. Commun. 2005, 327, 192-200.
29. Sebbag, M., Moinard, N., Auger, I., Clavel, C. et al., Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur. J. Immunol. 2006, 36, 2250-2263.
30. Zhao,X.,Okeke,N.L.,Sharpe,O.,Batliwalla,F.M.et al., Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res. Ther. 2008, 10,R94.